Pharmacokinetics of Efavirenz During Treatment of HIV-1 Infected Subjects With Hepatic Impairment.
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2010
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual and date (Mar 2008) and actual number of patients (11) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.